GB9818910D0 - Novel formulation - Google Patents

Novel formulation

Info

Publication number
GB9818910D0
GB9818910D0 GBGB9818910.3A GB9818910A GB9818910D0 GB 9818910 D0 GB9818910 D0 GB 9818910D0 GB 9818910 A GB9818910 A GB 9818910A GB 9818910 D0 GB9818910 D0 GB 9818910D0
Authority
GB
United Kingdom
Prior art keywords
novel formulation
formulation
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9818910.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9818910.3A priority Critical patent/GB9818910D0/en
Publication of GB9818910D0 publication Critical patent/GB9818910D0/en
Priority to ES99944497T priority patent/ES2193742T3/en
Priority to EP99944497A priority patent/EP1107787B1/en
Priority to AU57399/99A priority patent/AU5739999A/en
Priority to PT99944497T priority patent/PT1107787E/en
Priority to EP02079708A priority patent/EP1285666A1/en
Priority to DK99944497T priority patent/DK1107787T3/en
Priority to JP2000571026A priority patent/JP2002525277A/en
Priority to AT99944497T priority patent/ATE240118T1/en
Priority to CA002341703A priority patent/CA2341703A1/en
Priority to PCT/EP1999/006202 priority patent/WO2000012129A2/en
Priority to DE69907921T priority patent/DE69907921T2/en
Priority to CO99054147A priority patent/CO5090912A1/en
Priority to ARP990104274A priority patent/AR023643A1/en
Priority to US10/844,204 priority patent/US20040213806A1/en
Ceased legal-status Critical Current

Links

GBGB9818910.3A 1998-08-28 1998-08-28 Novel formulation Ceased GB9818910D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB9818910.3A GB9818910D0 (en) 1998-08-28 1998-08-28 Novel formulation
DE69907921T DE69907921T2 (en) 1998-08-28 1999-08-24 SALMONELLA TYPHI VACCINE COMPOSITIONS
DK99944497T DK1107787T3 (en) 1998-08-28 1999-08-24 Salmonella typhi vaccine composition
AT99944497T ATE240118T1 (en) 1998-08-28 1999-08-24 SALMONELLA TYPHI VACCINE COMPOSITIONS
AU57399/99A AU5739999A (en) 1998-08-28 1999-08-24 Salmonella typhi vaccine compositions
PT99944497T PT1107787E (en) 1998-08-28 1999-08-24 COMPOUNDS OF VACCINES AGAINST SALMONELLA TYPHI
EP02079708A EP1285666A1 (en) 1998-08-28 1999-08-24 Salmonella typhi vaccine compositions
ES99944497T ES2193742T3 (en) 1998-08-28 1999-08-24 VACCINE COMPOSITIONS CONTAINING SALMONELLA TYPHI.
JP2000571026A JP2002525277A (en) 1998-08-28 1999-08-24 Salmonellatyphi vaccine composition
EP99944497A EP1107787B1 (en) 1998-08-28 1999-08-24 Salmonella typhi vaccine compositions
CA002341703A CA2341703A1 (en) 1998-08-28 1999-08-24 Salmonella typhi vaccine compositions
PCT/EP1999/006202 WO2000012129A2 (en) 1998-08-28 1999-08-24 Salmonella typhi vaccine compositions
ARP990104274A AR023643A1 (en) 1998-08-28 1999-08-26 FORMULATIONS OF VACCINE OF MULTIPLE ANTIGENS
CO99054147A CO5090912A1 (en) 1998-08-28 1999-08-26 NOVEDOUS VACCINE COMBINATION UNDERSTANDING A POLISACARIUM Vi Salmonella typhi PURIFIED AND AT LEAST ANOTHER ANTIGE NO AND METHODS TO MAKE THE VACCINES
US10/844,204 US20040213806A1 (en) 1998-08-28 2004-05-12 Salmonella typhi vaccine compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9818910.3A GB9818910D0 (en) 1998-08-28 1998-08-28 Novel formulation

Publications (1)

Publication Number Publication Date
GB9818910D0 true GB9818910D0 (en) 1998-10-21

Family

ID=10838070

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9818910.3A Ceased GB9818910D0 (en) 1998-08-28 1998-08-28 Novel formulation

Country Status (2)

Country Link
CO (1) CO5090912A1 (en)
GB (1) GB9818910D0 (en)

Also Published As

Publication number Publication date
CO5090912A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
GB9804013D0 (en) Formulations
ZA9811461B (en) New formulation
GB9809058D0 (en) Composition
PL342600A1 (en) Composition
HK1026429A1 (en) New formulation
GB9812119D0 (en) Composition
EP1068213A4 (en) Novel aminoorganofunctionalsiloxanes
GB9806788D0 (en) Composition
GB9724544D0 (en) Novel Formulation
GB9827894D0 (en) Composition
GB9806793D0 (en) Composition
GB9806312D0 (en) Novel formulations
GB9725061D0 (en) Revitalisation formulation
GB9810180D0 (en) Novel formulation
GB9813714D0 (en) Composition
GB9706957D0 (en) Formulation
GB9903310D0 (en) Composition
GB9815002D0 (en) Formulations
GB9815001D0 (en) Formulations
GB9804041D0 (en) Composition
GB9810181D0 (en) Novel formulations
AU1649700A (en) Novel formulation
GB9806791D0 (en) Composition
GB9818905D0 (en) Novel formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)